Drug Type Chemical drugs |
Synonyms SER 400, SER400 |
Target |
Action modulators |
Mechanism α7 receptor modulators(Neuronal acetylcholine receptor protein alpha-7 subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | Canada | 27 Apr 2022 | |
Pain | Preclinical | Canada | 27 Apr 2022 |